logo-full arrow-left arrow-right magnify story members projects twitter facebook youtube download

In 2007 and 2008, the Global Treatment Access Group (GTAG) reviewed and validated its commitment to the right to health, to equity and to a ‘do no harm’ approach to HIV advocacy. This paper builds on that initiative by providing a brief overview of current health system discourse and by exploring the debate and advocacy themes as they related to GTAG’s core advocacy on HIV.

The development of a safe and effective AIDS vaccine is the primary goal of AIDS vaccine research and, once achieved, will have a remarkable impact on reducing the spread of HIV. But there are other added benefits. Conducting AIDS vaccine research in developing countries also strengthens their health systems by reinforcing their research capacity and contributing to health system functioning more broadly. This fact sheet examines the impact of AIDS vaccine research on health systems strengthening in five key areas: the training and retention of human resources; infrastructure development; institutional development; improved health services; and enhanced HIV services.

The aim of this fact sheet is to examine some of the main issues related to the causes and effects of the exodus of healthcare professionals. The fact sheet also examines the approaches being considered to solve this problem and possible solutions for the management of international migration that would be less detrimental to healthcare systems in developing countries.